ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$27.83
+0.32%
Mkt Cap $4.80B
Analyst Ratings
Buy
14
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
Implied Upside
+23.4%
Consensus $34.33 vs current $27.83
NASDAQ·Healthcare·Biotechnology
$27.83
+0.32%
Mkt Cap $4.80B
Buy
14
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
+23.4%
Consensus $34.33 vs current $27.83